"The World Market for Gynaecology- 2007-2017" comprehensively analyses prescription products used in infertility contraception, gynaecological disorders, and menopause. It reviews the entire range of current products giving out data on side effects and sales figures.

The report finds that the market for gynaecology is intrinsically linked to the use of hormonal drugs which have been recently the subject of controversy, as they have implicated in increasing the risk of cardiovascular disease and cancer. It says that the global market for these products has dipped because there is increased caution in prescribing hormone replacement therapies.

Gynaecological drug manufacturers are currently involved in reformulating hormonal drugs to solve market, clinical, and regulatory barriers. Authors point out that there are over 75 pipeline hormonal products in clinical development which will be instrumental in improving clinical effects as they are composed of purer analogues, lower-dose formulations, new modes of delivery and mechanisms of action. They have scrutinised these products and provided details of clinical trials as well.

"The World Market for Gynaecology- 2007-2017" is available in pdf format from Piribo. For more information, go to:

http://www.piribo.com/publications/therapeutic/women_health/world_market_gynaecology.html

Piribo product ID: SPE012

About Piribo.
Piribo (http:www.piribo.com) is a UK-based independent online store supplying business information on the pharmaceutical and biotechnology industries. The website now carries over 6,000 English language titles including, market reports, studies and books and is the UK's largest online biopharma information store. Subscribers receive a free monthly newsletter and email alerts on new titles in their areas of interest. The company was established in 2004.